India might get a COVID-19 vaccine by March 2021, revealed Dr Suresh Jadhav, government director, Serum Institute of India.
“India may get COVID-19 vaccine by March 2021 provided the regulators speed up the process as multiple manufacturers are working on it,” Jadhav stated on the India Vaccine Accessibility e-summit organised by HEAL Foundation in affiliation with ICCIDD.
India will get 60-70 million dosages of vaccines by December 2020 however they will come into the market in 2021 after the clearance of licensing, stated Dr Jadhav.
“India will get 60-70 million doses of Oxford vaccine Covishield by December but the vaccines will come to the market in March 2021. The time between December and March will be required for licensing,” Hindustan Times quoted Jadhav as saying.
At current, SII is conducting part 2 and three trials of the vaccine.
“India is heading fast towards vaccine development as two manufacturers are already in phase-3 trial and one in the phase-2 trial, while more players are joining the race,” the Indian Express quoted Jadhav as saying.
Serum Institute of India can produce 700-800 million vaccine dosages yearly as soon as issues are streamlined, he added.
On September 16, the Drugs Controller General of India (DCGI) allowed the SII to restart its part two and three scientific trials for the Oxford-AstraZeneca COVID-19 vaccine.
AstraZeneca had earlier paused the continued trial of the coronavirus vaccine (recombinant) as a volunteer had developed an unexplained sickness.
Pune-based drug maker partnered with British-Swedish firm AstraZeneca to fabricate COVID-19 vaccine candidate, developed by the University of Oxford.
The closing stage of the scientific trial of Oxford’s COVID-19 vaccine has already began within the nation.